INMInMed Pharmaceuticals Inc.
- Market cap
- $7.91M
- as of 2026-10-23
- Latest close
- $1.44
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Drug Manufacturers - Specialty & Generic
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2023-12-06
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| ADAR1 Capital Management, LLC | Oct 19 | Oct 20 | P | 1,086 | $1.32 | Purchase +$1,434 | 956,580 | No | Form 4 |
| ADAR1 Capital Management, LLC | Oct 16 | Oct 20 | P | 1 | $1.32 | Purchase +$1 | 955,494 | No | Form 4 |
| ADAR1 Capital Management, LLC | Oct 15 | Oct 15 | P | 984 | $1.32 | Purchase +$1,301 | 955,493 | No | Form 4 |
| ADAR1 Capital Management, LLC | Oct 14 | Oct 15 | P | 8,021 | $1.33 | Purchase +$10,668 | 954,509 | No | Form 4 |
| ADAR1 Capital Management, LLC | Oct 13 | Oct 15 | P | 564 | $1.33 | Purchase +$750 | 946,488 | No | Form 4 |
| ADAR1 Capital Management, LLC | Oct 8 | Oct 8 | P | 2,256 | $1.33 | Purchase +$2,997 | 945,924 | No | Form 4 |
| ADAR1 Capital Management, LLC | Oct 7 | Oct 8 | P | 3,046 | $1.33 | Purchase +$4,051 | 943,668 | No | Form 4 |
| ADAR1 Capital Management, LLC | Oct 6 | Oct 8 | P | 5,601 | $1.33 | Purchase +$7,436 | 940,622 | No | Form 4 |
| ADAR1 Capital Management, LLC | Oct 5 | Oct 5 | P | 18,182 | $1.33 | Purchase +$24,182 | 935,021 | No | Form 4 |
| ADAR1 Capital Management, LLC | Oct 2 | Oct 5 | P | 8,307 | $1.33 | Purchase +$11,048 | 916,839 | No | Form 4 |
| ADAR1 Capital Management, LLC | Oct 1 | Oct 5 | P | 16,431 | $1.33 | Purchase +$21,850 | 908,532 | No | Form 4 |
| Schneeberger Daniel | Sep 16 | Sep 16 | P | 8,340 | $1.29 | Purchase +$10,759 | 892,101 | No | Form 4 |
| Schneeberger Daniel | Sep 15 | Sep 16 | P | 54,256 | $1.30 | Purchase +$70,533 | 883,761 | No | Form 4 |
| Schneeberger Daniel | Sep 14 | Sep 16 | P | 28,505 | $1.29 | Purchase +$36,771 | 829,505 | No | Form 4 |
| ADAR1 Capital Management, LLC | Jul 15 | Jul 17 | P | 1,000 | $1.56 | Purchase +$1,560 | 801,000 | No | Form 4 |
| Vivo Opportunity Cayman Fund, L.P. | Jul 16 | Jul 16 | P | 19 | $1.55 | Purchase +$29 | 743,057 | No | Form 4 |
| Vivo Opportunity Cayman Fund, L.P. | Jul 16 | Jul 16 | P | 2 | $1.55 | Purchase +$3 | 75,019 | No | Form 4 |
| Vivo Opportunity Cayman Fund, L.P. | Jul 15 | Jul 16 | P | 13,761 | $1.55 | Purchase +$21,330 | 743,038 | No | Form 4 |
| Vivo Opportunity Cayman Fund, L.P. | Jul 15 | Jul 16 | P | 1,389 | $1.55 | Purchase +$2,153 | 75,017 | No | Form 4 |
| Vivo Opportunity Cayman Fund, L.P. | Jul 14 | Jul 16 | P | 4,882 | $1.55 | Purchase +$7,567 | 729,277 | No | Form 4 |
| Vivo Opportunity Cayman Fund, L.P. | Jul 14 | Jul 16 | P | 493 | $1.55 | Purchase +$764 | 73,628 | No | Form 4 |
| Vivo Opportunity, LLC | Jul 2 | Jul 2 | P | 1,460 | $1.55 | Purchase +$2,263 | 724,395 | No | Form 4 |
| Vivo Opportunity, LLC | Jul 2 | Jul 2 | P | 147 | $1.55 | Purchase +$228 | 73,135 | No | Form 4 |
| Vivo Opportunity, LLC | Jul 1 | Jul 2 | P | 3,946 | $1.55 | Purchase +$6,116 | 722,935 | No | Form 4 |
| Vivo Opportunity, LLC | Jul 1 | Jul 2 | P | 398 | $1.55 | Purchase +$617 | 72,988 | No | Form 4 |
| Vivo Opportunity, LLC | Jun 30 | Jul 2 | P | 545 | $1.54 | Purchase +$839 | 718,989 | No | Form 4 |
| Vivo Opportunity, LLC | Jun 30 | Jul 2 | P | 55 | $1.54 | Purchase +$85 | 72,590 | No | Form 4 |
| Vivo Opportunity, LLC | Jun 8 | Jun 10 | P | 29,518 | $1.52 | Purchase +$44,867 | 718,444 | No | Form 4 |
| Vivo Opportunity, LLC | Jun 8 | Jun 10 | P | 2,982 | $1.52 | Purchase +$4,533 | 72,535 | No | Form 4 |
| Vivo Opportunity, LLC | Jun 5 | Jun 10 | P | 49,966 | $1.57 | Purchase +$78,447 | 688,926 | No | Form 4 |
| Vivo Opportunity, LLC | Jun 5 | Jun 10 | P | 5,045 | $1.57 | Purchase +$7,921 | 69,553 | No | Form 4 |
| Vivo Opportunity, LLC | Jun 4 | Jun 10 | P | 6,125 | $1.57 | Purchase +$9,616 | 638,960 | No | Form 4 |
| Vivo Opportunity, LLC | Jun 4 | Jun 10 | P | 618 | $1.57 | Purchase +$970 | 64,508 | No | Form 4 |
| Vivo Opportunity, LLC | Jun 3 | Jun 10 | P | 7,069 | $1.55 | Purchase +$10,957 | 632,835 | No | Form 4 |
| Vivo Opportunity, LLC | Jun 3 | Jun 10 | P | 714 | $1.55 | Purchase +$1,107 | 63,890 | No | Form 4 |
| Vivo Opportunity, LLC | Jun 2 | Jun 10 | P | 20,753 | $1.52 | Purchase +$31,545 | 625,766 | No | Form 4 |
| Vivo Opportunity, LLC | Jun 2 | Jun 10 | P | 2,095 | $1.52 | Purchase +$3,184 | 63,176 | No | Form 4 |
| Vivo Opportunity, LLC | Jun 1 | Jun 10 | P | 14,838 | $1.55 | Purchase +$22,999 | 605,013 | No | Form 4 |
| Vivo Opportunity, LLC | Jun 1 | Jun 10 | P | 1,498 | $1.55 | Purchase +$2,322 | 61,081 | No | Form 4 |
| Vivo Opportunity, LLC | May 29 | Jun 10 | P | 16,164 | $1.57 | Purchase +$25,377 | 590,175 | No | Form 4 |
| Vivo Opportunity, LLC | May 29 | Jun 10 | P | 1,632 | $1.57 | Purchase +$2,562 | 59,583 | No | Form 4 |
| Vivo Opportunity, LLC | May 21 | Jun 10 | P | 30,882 | $1.69 | Purchase +$52,191 | 574,011 | No | Form 4 |
| Vivo Opportunity, LLC | May 21 | Jun 10 | P | 3,118 | $1.69 | Purchase +$5,269 | 57,951 | No | Form 4 |
| Vivo Opportunity, LLC | May 20 | Jun 10 | P | 51,056 | $1.56 | Purchase +$79,647 | 543,129 | No | Form 4 |
| Vivo Opportunity, LLC | May 20 | Jun 10 | P | 5,154 | $1.56 | Purchase +$8,040 | 54,833 | No | Form 4 |
| Schneeberger Daniel | May 19 | May 21 | P | 68,551 | $1.60 | Purchase +$109,682 | 400,000 | No | Form 4 |
| Schneeberger Daniel | May 19 | May 21 | P | 200,000 | $1.56 | Purchase +$312,000 | 600,000 | No | Form 4 |
| Schneeberger Daniel | May 19 | May 21 | P | 200,000 | $1.50 | Purchase +$300,000 | 800,000 | No | Form 4 |
| Hull Andrew | Dec 19, 2025 | Dec 19, 2025 | A · derivative | 1,750 | $1.29 | $2,258 | 2,711 | No | Form 4 |
| Adams Eric APresident & CEO | Dec 19, 2025 | Dec 19, 2025 | A · derivative | 35,000 | $1.29 | $45,150 | 49,050 | No | Form 4 |
| Hsu Eric CSr. VP, Pre-Clinical Res/Dev | Dec 19, 2025 | Dec 19, 2025 | A · derivative | 13,000 | $1.29 | $16,770 | 18,280 | No | Form 4 |
| Bathery John Steven | Dec 19, 2025 | Dec 19, 2025 | A · derivative | 1,750 | $1.29 | $2,258 | 5,250 | No | Form 4 |
| Woudenberg MichaelChief Operating Officer | Dec 19, 2025 | Dec 19, 2025 | A · derivative | 18,000 | $1.29 | $23,220 | 25,445 | No | Form 4 |
| Jagpal NettaChief Financial Officer | Dec 19, 2025 | Dec 19, 2025 | A · derivative | 18,000 | $1.29 | $23,220 | 24,250 | No | Form 4 |
| Klompas Neil A | Dec 19, 2025 | Dec 19, 2025 | A · derivative | 1,750 | $1.29 | $2,258 | 5,250 | No | Form 4 |
| Lemerond Nicole | Dec 19, 2025 | Dec 19, 2025 | A · derivative | 1,750 | $1.29 | $2,258 | 2,725 | No | Form 4 |
| Johnson Shane AaronSr VP & General Manager | Dec 19, 2025 | Dec 19, 2025 | A · derivative | 8,500 | $1.29 | $10,965 | 12,400 | No | Form 4 |
| Hsu Eric CSr. VP, Pre-Clinical Res/Dev | Dec 15, 2025 | Dec 17, 2025 | H · derivative | 70 | $1,397.97 | $97,858 | 5,280 | No | Form 4 |
| Woudenberg MichaelChief Operating Officer | Dec 15, 2025 | Dec 17, 2025 | H · derivative | 60 | $1,397.97 | $83,878 | 7,445 | No | Form 4 |
| Adams Eric APresident & CEO | Dec 15, 2025 | Dec 17, 2025 | H · derivative | 250 | $1,397.97 | $349,493 | 14,050 | No | Form 4 |
| Hull Andrew | Dec 15, 2025 | Dec 17, 2025 | H · derivative | 14 | $1,397.97 | $19,572 | 961 | No | Form 4 |
| Klompas Neil A | Oct 17, 2025 | Oct 21, 2025 | A · derivative | 3,500 | $2.10 | $7,350 | 3,500 | No | Form 4 |
| Hull Andrew | Jan 11, 2025 | Feb 3, 2025 | H · derivative | 2 | $2,860.21 | $5,720 | 975 | No | Form 4 |
| Hull Andrew | Dec 20, 2024 | Dec 23, 2024 | A · derivative | 550 | $4.14 | $2,277 | 977 | No | Form 4 |
| Baldasare Bryan T | Dec 20, 2024 | Dec 23, 2024 | A · derivative | 550 | $4.14 | $2,277 | 975 | No | Form 4 |
| Adams Eric APresident & CEO | Dec 20, 2024 | Dec 23, 2024 | A · derivative | 6,250 | $4.14 | $25,875 | 14,300 | No | Form 4 |
| Hsu Eric CSr. VP, Pre-Clinical Res/Dev | Dec 20, 2024 | Dec 23, 2024 | A · derivative | 2,750 | $4.14 | $11,385 | 5,350 | No | Form 4 |
| Grove Janet P | Dec 20, 2024 | Dec 23, 2024 | A · derivative | 550 | $4.14 | $2,277 | 975 | No | Form 4 |
| Woudenberg MichaelChief Operating Officer | Dec 20, 2024 | Dec 23, 2024 | A · derivative | 3,750 | $4.14 | $15,525 | 7,505 | No | Form 4 |
| Lemerond Nicole | Dec 20, 2024 | Dec 23, 2024 | A · derivative | 550 | $4.14 | $2,277 | 975 | No | Form 4 |
| Jagpal NettaChief Financial Officer | Dec 20, 2024 | Dec 23, 2024 | A · derivative | 3,750 | $4.14 | $15,525 | 6,250 | No | Form 4 |
| Johnson Shane AaronSr VP & General Manager | Dec 20, 2024 | Dec 23, 2024 | A · derivative | 1,500 | $4.14 | $6,210 | 3,900 | No | Form 4 |
| Mancini Alexandra Diane Janet | Jul 31, 2024 | Aug 2, 2024 | S | 240 | $0.18 | Sale −$43 | not reported | No | Form 4 |
| Mancini Alexandra Diane JanetSr VP, Clinical Reg Affairs | May 27, 2024 | May 28, 2024 | H · derivative | 485 | $263.18 | $127,642 | 52,000 | No | Form 4 |
| Adams Eric APresident & CEO | May 27, 2024 | May 28, 2024 | H · derivative | 1,139 | $263.18 | $299,762 | 161,000 | No | Form 4 |
| Hsu Eric CSr. VP, Pre-Clinical Res/Dev | May 27, 2024 | May 28, 2024 | H · derivative | 545 | $263.18 | $143,433 | 52,000 | No | Form 4 |
| Woudenberg MichaelChief Operating Officer | May 27, 2024 | May 28, 2024 | H · derivative | 394 | $263.18 | $103,693 | 75,100 | No | Form 4 |
| Hsu Eric CSr. VP, Pre-Clinical Res/Dev | Mar 4, 2024 | Mar 5, 2024 | H · derivative | 309 | $364.72 | $112,698 | 52,545 | No | Form 4 |
| Mancini Alexandra Diane JanetSr VP, Clinical Reg Affairs | Jan 21, 2024 | Mar 5, 2024 | H · derivative | 121 | $312.73 | $37,840 | 52,485 | No | Form 4 |
| Hull Andrew | Jan 14, 2024 | Mar 5, 2024 | H · derivative | 42 | $307.01 | $12,894 | 8,542 | No | Form 4 |
| Hull Andrew | Feb 21, 2024 | Feb 22, 2024 | P | 37,500 | $0.39 | Purchase +$14,625 | 38,258 | No | Form 4 |
| Adams Eric APresident & CEO | Feb 20, 2024 | Feb 21, 2024 | P | 41,600 | $0.36 | Purchase +$14,976 | 43,959 | No | Form 4 |
| Hull Andrew | Dec 23, 2023 | Dec 26, 2023 | A · derivative | 7,100 | $0.37 | $2,627 | 8,584 | No | Form 4 |
| Mancini Alexandra Diane JanetSr VP, Clinical Reg Affairs | Dec 23, 2023 | Dec 26, 2023 | A · derivative | 45,000 | $0.37 | $16,650 | 52,606 | No | Form 4 |
| Baldasare Bryan T | Dec 23, 2023 | Dec 26, 2023 | A · derivative | 7,100 | $0.37 | $2,627 | 8,500 | No | Form 4 |
| Adams Eric APresident & CEO | Dec 23, 2023 | Dec 26, 2023 | A · derivative | 136,000 | $0.37 | $50,320 | 162,139 | No | Form 4 |
| Hsu Eric CSr. VP, Pre-Clinical Res/Dev | Dec 23, 2023 | Dec 26, 2023 | A · derivative | 45,000 | $0.37 | $16,650 | 52,854 | No | Form 4 |
| Grove Janet P | Dec 23, 2023 | Dec 26, 2023 | A · derivative | 7,100 | $0.37 | $2,627 | 8,500 | No | Form 4 |
| Tegge JonathanInterim CFO | Dec 23, 2023 | Dec 26, 2023 | A · derivative | 30,000 | $0.37 | $11,100 | 31,400 | No | Form 4 |
| Woudenberg MichaelChief Operating Officer | Dec 23, 2023 | Dec 26, 2023 | A · derivative | 65,000 | $0.37 | $24,050 | 75,494 | No | Form 4 |
| Lemerond Nicole | Dec 23, 2023 | Dec 26, 2023 | A · derivative | 7,100 | $0.37 | $2,627 | 8,500 | No | Form 4 |
| Johnson Shane AaronSr VP & General Manager | Dec 23, 2023 | Dec 26, 2023 | A · derivative | 40,000 | $0.37 | $14,800 | 48,000 | No | Form 4 |
| Woudenberg MichaelChief Operating Officer | Dec 5, 2023 | Dec 6, 2023 | H · derivative | 848 | $270.36 | $229,265 | 10,494 | No | Form 4 |